40% of Pharma Companies Are Including Savings from Generative AI in 2024 Budgets

Pharma companies have high confidence in the value of generative artificial intelligence (AI).

According to a recent Bain survey:

  • 40% of executives say that they are included expected savings into their 2024 budget
  • 60% have set targets for cost savings or productivity boosts

Sign up for the weekly email newsletter

Join the PharmaSource newsletter for weekly insights in biopharma.
Who do you rate?
Recommend a Supplier

Help us find the most innovative and trusted suppliers in Pharma and Biotech.